z-logo
open-access-imgOpen Access
Intermittent neonatal hypoxia elicits the upregulation of inflammatory‐related genes in adult male rats through long‐lasting programming effects
Author(s) -
Gehrand Ashley L.,
Kaldunski Mary L.,
Bruder Eric D.,
Jia Shuang,
Hessner Martin J.,
Raff Hershel
Publication year - 2015
Publication title -
physiological reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 39
ISSN - 2051-817X
DOI - 10.14814/phy2.12646
Subject(s) - intermittent hypoxia , hypoxia (environmental) , downregulation and upregulation , medicine , cxcl1 , endocrinology , peripheral blood mononuclear cell , chemokine , population , microarray , inflammation , obstructive sleep apnea , gene expression , andrology , biology , gene , chemistry , biochemistry , environmental health , organic chemistry , oxygen , in vitro
The long‐term effects of neonatal intermittent hypoxia ( IH ), an accepted model of apnea‐induced hypoxia, are unclear. We have previously shown lasting “programming” effects on the HPA axis in adult rats exposed to neonatal IH . We hypothesized that neonatal rat exposure to IH will subsequently result in a heightened inflammatory state in the adult. Rat pups were exposed to normoxia (control) or six cycles of 5% IH or 10% IH over one hour daily from postnatal day 2–6. Plasma samples from blood obtained at 114 days of age were analyzed by assessing the capacity to induce transcription in a healthy peripheral blood mononuclear cell ( PBMC ) population and read using a high‐density microarray. The analysis of plasma from adult rats previously exposed to neonatal 5% IH versus 10% IH resulted in 2579 significantly regulated genes including increased expression of Cxcl1, Cxcl2, Ccl3, Il1a , and Il1b . We conclude that neonatal exposure to intermittent hypoxia elicits a long‐lasting programming effect in the adult resulting in an upregulation of inflammatory‐related genes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here